5 Cheap Small-Cap Stocks to Buy Before the Next Breakout

2. Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Number of Hedge Fund Holders: 39

Share Price as of December 7: $6.40

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is a San Carlos, California-based biotech company founded in 2007 with a focus on developing tumor-infiltrating lymphocyte therapies against cancer. The company intends to use the power of the human immune system and create the first one-time cell therapy to treat solid tumor cancer.

Reni Benjamin at JMP Securities assigned Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) stock a target price of $21 along with an Outperform rating in a note issued to investors on November 21. The analyst incorporated the impact of the delay in the filing of the Biologics License Application for lifileucel from Q4 2022 to Q1 2023. Benjamin concluded that Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the best small-cap stocks as it offers a unique investment opportunity to potential investors due to the company’s strong cash position of $366.6 million and continuous progress in research to combat solid tumors. Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) has taken its study to the next level by conducting combination research with checkpoint inhibitors.

Follow Iovance Biotherapeutics Inc. (NASDAQ:IOVA)